Patient is a know history of methamphetamine usage since 2021 One month prior to consultation (PTC), the patient was reported by the significant other (SO) to have become intoxicated with alcohol and behaved aggressively. He repeatedly shouted, "Kinsay isog?" entered another person's house without permission, disturbed the others and spoke to them aggressively. The police were called and got arrested , the patient spit at a police officer, and an illegal possession of firearm caused him to remain in jail longer. While in prison, the SO noted that he would speak incoherently ("pataka na ug sturya") and was unable to answer questions appropriately. During the SO's visits, he would cry and repeatedly express worry about his child. After getting released, he stayed at home, exhibited poor sleep and appetite, neglected personal hygiene, and rarely went outside. Three days PTC, the patient's live-in partner called and informed him that she would send their child to visit. Following this, the patient was unable to sleep, cried frequently, appeared worried, and began speaking incoherently. Two days PTC, the patient continued to have poor sleep and frequent crying, and was noted to shout randomly. He repeatedly insisted that his live-in partner was still at home, despite her having already left the city. The night PTC, the patient remained awake throughout the night cleaning the house, believing that his children would be arriving. By dawn, he became increasingly agitated as his child had still not arrived. On the day of consultation, the children did not arrive because their maternal grandfather did not permit the visit. Morning PTC, patient verbalized "Manago ta kay daghan manulong" "Naa koy makit an babaye ug lalaki." Patient ran inside to his room. He was followed by his father. He punched and kicked his father unprovoked. He said "Buang ko! Buang ko!" He threw anything he can hold and slammed the walls. He was seen waving a scissors. Due to his persistent agitation, aggression, and the family's inability to control his behavior, he was brought to VSMMC-CBS CMU for further evaluation and management This is a history of my patient . I'm having a case presentation so the doctor is gonna ask me questions in this. So please do prepare me for all the level of questions from here
methamphetamine psychosis diagnosis management
methamphetamine induced psychosis schizophrenia differential
| Timeframe | Events |
|---|---|
| Since 2021 | Methamphetamine use begins |
| 1 month PTC | Alcohol intoxication + aggression, arrested, jailed |
| While in jail | Incoherent speech, crying, worried about child |
| Post-release | Poor sleep, poor appetite, hygiene neglect, social withdrawal |
| 3 days PTC | Sleeplessness, frequent crying, incoherence after news of child's visit |
| 2 days PTC | Poor sleep, shouting randomly, fixed false belief (partner still home) |
| Night PTC | Sleeplessness, psychomotor agitation (cleaning all night), anticipatory delusion |
| Day of consult | Hallucinations, unprovoked violence, agitation, dangerous behavior |
| Feature | Meth-Induced Psychosis | Schizophrenia |
|---|---|---|
| Temporal onset | After/during drug use | May predate substance use |
| Duration | Usually resolves within days-weeks of abstinence | Persistent >6 months |
| Symptom resolution | Improves with abstinence | Persists despite abstinence |
| Hallucinations type | Tactile (formication), visual during acute intox; auditory in persistent | Predominantly auditory |
| Insight | Often relatively preserved | Often impaired |
| Family history | Less likely | More common |
| Negative symptoms | Less prominent (except in withdrawal/crash) | Often prominent |
| Anxiety | Common | Less common |
| Feature | Stimulant Intoxication | GBL/GHB Withdrawal |
|---|---|---|
| Autonomic hyperactivity | Yes | Yes |
| Agitation | Yes | Yes |
| Hallucinations | Yes | Yes |
| Overlap | High | High |
| Treatment difference | Lower benzo doses often sufficient | Requires higher benzo doses and more prolonged treatment |
| Domain | Key Point |
|---|---|
| Diagnosis | Stimulant (meth)-induced psychotic disorder, DSM-5-TR |
| Core symptoms | Persecutory delusions, visual hallucinations, disorganized speech, psychomotor agitation |
| Key red flag | Psychosis in jail (substance-free) → consider primary psychotic disorder |
| Violence risk | High - psychosis + meth + sleep deprivation + prior assault + weapon use |
| Acute Rx | Benzodiazepines (diazepam 5-10 mg q4-6h) first; olanzapine or aripiprazole if antipsychotic needed; AVOID haloperidol |
| Prognosis | Most resolve 2-3 weeks; 25% still symptomatic at 1 month; 16-38% later diagnosed with schizophrenia |
| Key textbook | Maudsley Prescribing Guidelines 15th ed; Kaplan & Sadock Comprehensive Textbook of Psychiatry |
| Recent evidence | PMID 38554698 (2024 meta-analysis): meth psychosis has more positive, fewer negative symptoms vs. schizophrenia |
Btw what is delusion teach in easy English
| Rule | What it means |
|---|---|
| False | The belief is not true |
| Fixed | The person will not change their mind, no matter what |
| Not shared by others | Other people in the same culture/community do NOT believe it |
Patient insisted his live-in partner was still at home - even though she had already left the city.
| Type | What the person believes |
|---|---|
| Persecutory (most common) | "Someone is out to get me / spy on me / hurt me" |
| Grandiose | "I am a special person / I have superpowers / I am very important" |
| Reference | "That news anchor on TV is talking directly about me" |
| Jealous | "My partner is cheating on me" (with no real proof) |
| Somatic | "There are bugs living inside my body" |
| Erotomanic | "A famous person is secretly in love with me" |
| Normal Worry | Delusion |
|---|---|
| "I think my partner might be angry at me" | "My partner is conspiring to take my child away and has people watching me" |
| Can be talked out of it with good evidence | Cannot be talked out of it at all |
| Proportional to the situation | Way out of proportion, or completely made up |
| Comes and goes | Fixed and persistent |
"A delusion is a fixed, false, unshakeable belief that is not culturally accepted and persists despite clear contradictory evidence."
What is illusion, just how it's different from delusion
You see a rope on the floor in the dark → your brain says "SNAKE!" → you jump. You look again with the lights on → it's just a rope.
| Illusion | Delusion | |
|---|---|---|
| What it is | A perception error | A belief/thought error |
| Real stimulus? | YES - something real is there | Does not need one |
| Correctable? | YES - once you look again / think again | NO - person cannot be corrected |
| Category | Disorder of perception | Disorder of thought content |
| Situation | Illusion | Delusion |
|---|---|---|
| Sees shadows at night | "That shadow looks like a person" - then realizes it's just a curtain | "There IS a person hiding in my house to kill me" - refuses to believe otherwise |
| Hears wind outside | "That sounded like someone calling my name" - then dismisses it | "The neighbors are using a device to beam voices into my head" |
| Partner comes home late | "For a second I thought that stranger at the door was my partner" | "My partner is definitely cheating on me with that person" (with no proof, unshakeable) |
| Term | Simple meaning | Real stimulus? | Correctable? |
|---|---|---|---|
| Illusion | Misread something real | YES | YES |
| Hallucination | Perceive something with NO real stimulus | NO | No (in the moment) |
| Delusion | False unshakeable belief | Not relevant | NO |
Illusion = real thing, wrong interpretation. Delusion = false belief, nothing can change it. They are completely different categories - one is a perception error, the other is a thinking error.
Now what is delusion vs hallucination and vs illusion
| Term | Brain Function Affected | One-Word Tag |
|---|---|---|
| Illusion | Perception - misreads something real | Misinterpret |
| Hallucination | Perception - creates something from nothing | Invent |
| Delusion | Thought/Belief - holds a false idea unshakably | Misjudge |
REAL OBJECT EXISTS?
|
YES → Brain reads it WRONG → ILLUSION
|
NO → Brain creates it anyway → HALLUCINATION
BELIEF IS FALSE + UNSHAKEABLE → DELUSION
(This is a thinking problem, not a seeing/hearing problem)
Something REAL is there. Your brain misreads it.
NOTHING is there. Your brain invents it completely.
A belief - not a perception. Your brain refuses to accept reality.
John is walking home alone at night.
| Feature | Illusion | Hallucination | Delusion |
|---|---|---|---|
| Type of problem | Perception | Perception | Thought/Belief |
| Real stimulus present? | YES | NO | Not applicable |
| Can be corrected? | YES, easily | No (in that moment) | NO, never |
| Senses involved? | Yes (wrong reading) | Yes (false experience) | No (it's a belief) |
| Normal people get it? | YES (fatigue, fear) | Rarely (extreme stress, sleep deprivation) | NO - always pathological |
| Example | Rope mistaken for snake | Hearing voices in an empty room | "The government is watching me" with no proof |
| In your patient | Possibly (figures in shadows) | "Naa koy makit-an babaye ug lalaki" - seeing people not there | Believing partner is still home despite leaving |
| Illusion | Wrong channel - real signal, wrong reading |
| Hallucination | Ghost signal - no channel, but brain invents one |
| Delusion | Wrong software - the thinking system itself is broken |
What are the effects of methamphetamine
| Effect | What the person experiences |
|---|---|
| Euphoria | Intense rush of happiness, pleasure - "best feeling ever" |
| Increased energy | Feels like they can do anything, won't get tired |
| Decreased need for sleep | Can stay awake for days |
| Decreased appetite | Doesn't feel hungry at all |
| Hyperfocus | Intense concentration on one task (like your patient cleaning all night) |
| Increased confidence | Feels powerful, invincible |
| Increased talkativeness | Can't stop talking |
| Increased libido | Strong sexual urges |
| Agitation/irritability | Easily angered, short fuse |
| Effect | Why |
|---|---|
| Fast heart rate (tachycardia) | Norepinephrine surge |
| High blood pressure | Vasoconstriction + cardiac stimulation |
| Dilated pupils (mydriasis) | Sympathetic activation |
| Dry mouth | Reduced saliva |
| Elevated body temperature (hyperthermia) | Increased metabolism |
| Sweating | Thermoregulatory response |
| Jaw clenching / bruxism | Repetitive motor activity |
| Tremors | Excess stimulation |
| Symptom | Why |
|---|---|
| Extreme fatigue | Brain has no dopamine left |
| Prolonged sleep (hypersomnia) | Body trying to recover |
| Intense hunger | Body catching up |
| Severe depression / dysphoria | No dopamine = no pleasure |
| Anhedonia | Can't feel happy from anything |
| Irritability | Low serotonin and dopamine |
| Intense cravings | Brain wants the dopamine flood back |
This is where your patient was after jail - poor sleep, poor appetite, hygiene neglect, social withdrawal = the crash/withdrawal phase.
| Condition | Notes |
|---|---|
| Psychosis | Paranoia, hallucinations, delusions - can persist for months |
| Depression | Often severe; related to dopamine depletion |
| Anxiety disorders | Panic attacks, generalized anxiety |
| Aggression and violence | Especially during intoxication or psychosis |
| High suicide risk | Especially during crash/withdrawal |
| Sensitization | Psychosis comes back faster and with less drug over time |
| System | Effect |
|---|---|
| Heart | Cardiomyopathy, arrhythmias, heart attack (even in young people) |
| Blood vessels | Vasculitis, stroke, brain hemorrhage from hypertension spikes |
| Lungs | Pulmonary hypertension (with IV use) |
| Kidneys | Acute kidney injury during hyperthermia/rhabdomyolysis |
| Liver | Hepatotoxicity |
| Immune system | Suppressed; higher infection risk |
| Teeth ("Meth mouth") | Severe dental decay - dry mouth + teeth grinding + poor hygiene |
| Skin | Sores from scratching (formication), poor wound healing |
| Weight | Severe malnutrition and weight loss |
| Sexual health | Increases risky sexual behavior → HIV, Hepatitis C risk |
| Phase | Key Effects |
|---|---|
| Immediate | Euphoria, energy, no sleep/appetite, fast heart, high BP |
| Binge | Paranoia, hallucinations, repetitive behavior, hyperthermia |
| Crash | Crash/depression, extreme fatigue, anhedonia, cravings |
| Chronic | Brain damage, psychosis, heart disease, stroke, dental decay, violence |
| Withdrawal | Dysphoric mood, insomnia/hypersomnia, suicidal ideation |
| Your patient's symptom | Meth effect behind it |
|---|---|
| Stayed awake all night cleaning | Acute stimulant effect - hyperfocus + sleeplessness |
| Poor appetite, neglected hygiene after jail | Crash/withdrawal phase |
| Seeing people not there | Visual hallucinations from meth psychosis |
| Believing partner was still home | Delusion from meth-sensitized dopaminergic overdrive |
| Punching father, throwing things | Psychosis-driven aggression (meth use is independently linked to violence) |
| "Buang ko!" | Partial insight still present despite severe psychosis |
Why does he have hallucinations and illusion and delision
"EVERYTHING IS IMPORTANT. EVERYTHING IS A SIGNAL. EVERYTHING IS REAL."
"Naa koy makit-an babaye ug lalaki" - "I see a man and a woman"
He insisted his live-in partner was still at home despite her having left the city.
| His brain's problem | His brain's "solution" (the delusion) |
|---|---|
| Unbearable anxiety that his family is gone | "She's still here - she hasn't really left" |
| Fear of abandonment + missing his child | "The children are coming tonight - I must prepare" |
| Hypervigilant dopamine system on overdrive | Turns normal ambiguity into "certainty" |
METH (4 years)
↓
Dopamine system oversensitized
↓
Everything feels threatening and meaningful (aberrant salience)
↓
┌─────────────────────────────────────────────┐
│ │
ILLUSION HALLUCINATION DELUSION
(Misreads real (Invents people/ (Invents a story
shadows/sounds) voices from to explain it all)
nothing)
│ │
└──────────── All confirm each other ─────────┘
↓
MORE FEAR → MORE AGITATION → MORE PSYCHOSIS
↓
Punches father / waves scissors
| Factor | Effect on brain |
|---|---|
| 4 years of meth use | Sensitized dopamine system - psychosis threshold is very low |
| Entire night without sleep | Brain enters dreamlike state while awake |
| Extreme emotional stress (children not arriving) | Amygdala goes into overdrive, floods cortex with threat signals |
| Anticipation + disappointment (children were supposed to come but didn't) | Unbearable emotional pain → brain defends itself with delusion |
"The patient's chronic methamphetamine use caused sensitization of the dopaminergic mesolimbic pathway, resulting in aberrant salience, impaired reality monitoring, and failure of the prefrontal cortex to distinguish internally generated perceptions from real external stimuli - producing hallucinations, illusions, and delusions that are further amplified by severe sleep deprivation and acute psychosocial stressors."
Methamphetamine Induced Psychotic Disorder Methamphetamine Use Disorder, Severe It's the diagnosis by our doctor. Just tell me how to rule in this diagnosis or how you come up with diagnosis on what basis??
| Criteria Met | Severity |
|---|---|
| 2-3 criteria | Mild |
| 4-5 criteria | Moderate |
| 6 or more criteria | SEVERE ← your patient |
| # | Criterion | Your Patient |
|---|---|---|
| 1 | Uses more or longer than intended | ✅ Using since 2021 - 4+ years, escalating |
| 2 | Persistent desire or failed efforts to cut down | Implied by continued use despite consequences |
| 3 | Spends a lot of time obtaining, using, or recovering | ✅ Lifestyle organized around use |
| 4 | Craving - strong urge to use | ✅ Implied by chronic daily-pattern use |
| # | Criterion | Your Patient |
|---|---|---|
| 5 | Failure to fulfill major role obligations (work, family) | ✅ Cannot care for his child, failed as a partner/father |
| 6 | Continued use despite social/interpersonal problems caused by the substance | ✅ Partner left, family destroyed - still using |
| 7 | Abandoned important activities (social, work, recreational) | ✅ Rarely went outside, neglected hygiene, social withdrawal |
| # | Criterion | Your Patient |
|---|---|---|
| 8 | Recurrent use in physically hazardous situations | ✅ Combined with alcohol, possessed illegal firearm while using |
| 9 | Continued use despite knowing it causes physical or psychological problems | ✅ Already developed psychosis - still used |
| # | Criterion | Your Patient |
|---|---|---|
| 10 | Tolerance - needs more to get the same effect | ✅ Implied by 4+ years of use (tolerance always develops with chronic meth) |
| 11 | Withdrawal - gets sick when stops | ✅ Post-jail period: poor sleep, poor appetite, depression, social withdrawal = classic meth withdrawal/crash |
| Psychotic Feature | Evidence in Patient |
|---|---|
| Hallucinations (Visual) | ✅ "Naa koy makit-an babaye ug lalaki" - sees a man and woman not there |
| Delusion (Fixed false belief) | ✅ Insisted partner was still home despite having left the city |
| Disorganized speech | ✅ "Pataka na ug sturya" - incoherent, unable to answer questions |
| Requirement | Evidence in Patient |
|---|---|
| Symptoms developed during or soon after intoxication or withdrawal | ✅ Psychotic features emerged in the context of known chronic meth use |
| The substance is known to cause psychosis | ✅ Methamphetamine is explicitly documented to cause psychosis |
| Feature | Your Patient |
|---|---|
| Did psychosis exist BEFORE meth use? | No documented prior psychiatric history before 2021 |
| Does it persist 1 month after stopping? | Not yet established - still being evaluated |
| Partial insight preserved? | ✅ "Buang ko! Buang ko!" - knows something is wrong |
| Symptoms match meth psychosis pattern? | ✅ Visual hallucinations + persecutory delusions = classic meth profile |
Honest caveat: The episode in jail (psychosis without drug access) is a yellow flag - this is why the patient needs close follow-up. If psychosis persists after abstinence, the diagnosis may shift to a primary psychotic disorder.
| Requirement | Evidence in Patient |
|---|---|
| Patient is NOT in a state of delirium | ✅ He is oriented (recognizes family, speaks to them, has organized behavior like cleaning) - not delirious |
| Requirement | Evidence in Patient |
|---|---|
| Symptoms are severe enough to need clinical attention | ✅ Family completely unable to control him, brought to emergency psychiatric unit |
| Key reason | Evidence |
|---|---|
| Temporal relationship | Psychiatric symptoms appeared after/during meth use onset in 2021 |
| No prior psychiatric history | No documented psychosis before meth use |
| Meth is a known cause | Well-established in literature |
| Symptoms match meth psychosis pattern | Visual hallucinations + paranoid delusions + agitation |
| Partial insight | Suggests not fully primary psychosis |
"We diagnosed Methamphetamine Use Disorder, Severe because the patient meets at least 8 of the 11 DSM-5-TR criteria across all four domains - impaired control, social impairment, risky use, and pharmacologic dependence - including tolerance, withdrawal symptoms, continued use despite harm, and significant role failure over a 4-year period.
We diagnosed Methamphetamine-Induced Psychotic Disorder because the patient fulfills DSM-5-TR Criterion A with both hallucinations and delusions, Criterion B with symptoms temporally linked to chronic methamphetamine use, Criterion C as there is no prior psychiatric history predating substance use and partial insight is preserved, Criterion D as delirium has been excluded, and Criterion E given the severity requiring emergency psychiatric admission."
Methamphetamine induces psychotic disorder comes under which class of substances use disorder in DSM5 book?
Stimulant-Related Disorders
| # | Class | Examples |
|---|---|---|
| 1 | Alcohol | Beer, wine, spirits |
| 2 | Caffeine | Coffee, energy drinks |
| 3 | Cannabis | Marijuana, THC |
| 4 | Hallucinogens | LSD, psilocybin, PCP |
| 5 | Inhalants | Glue, paint, solvents |
| 6 | Opioids | Heroin, morphine, oxycodone |
| 7 | Sedatives / Hypnotics / Anxiolytics | Benzodiazepines, barbiturates |
| 8 | ➡️ STIMULANTS | Methamphetamine, amphetamine, cocaine |
| 9 | Tobacco | Nicotine |
| 10 | Other / Unknown | Anabolic steroids, etc. |
| Disorder | Your Patient |
|---|---|
| Stimulant Use Disorder (mild / moderate / severe) | ✅ Diagnosed |
| Stimulant Intoxication | Possible |
| Stimulant Withdrawal | ✅ Post-jail period |
| Stimulant-Induced Psychotic Disorder | ✅ Diagnosed |
| Stimulant-Induced Bipolar Disorder | Consider |
| Stimulant-Induced Depressive Disorder | Consider (crash phase) |
| Stimulant-Induced Anxiety Disorder | Present |
| Stimulant-Induced Sleep Disorder | ✅ Prominent |
"Methamphetamine-induced psychotic disorder falls under Stimulant-Related Disorders, which is one of the ten substance-related disorder classes in DSM-5, after DSM-5 merged the previously separate cocaine and amphetamine categories into a single stimulant class."
Just why to rule in the schizophrenia and bipolar 1 here just corelate with mey patient
"What else COULD this be, based on what I see?"
| Schizophrenia Criterion | Your Patient's Evidence | Match? |
|---|---|---|
| Delusions | Believed partner was still home despite leaving; believed children were arriving all night | ✅ |
| Hallucinations | "Naa koy makit-an babaye ug lalaki" - visual hallucinations | ✅ |
| Disorganized speech | "Pataka na ug sturya" - spoke incoherently, couldn't answer questions | ✅ |
| Grossly disorganized behavior | Waving scissors, throwing objects, punching father, cleaning obsessively all night | ✅ |
| Functional decline | Stopped going outside, neglected hygiene, failed as a partner and father | ✅ |
| Duration >1 month? | Psychosis noted in jail + post-jail + day of consult = weeks to a month | ⚠️ Borderline |
He was psychotic INSIDE JAIL - where he had no access to methamphetamine.
| Reason to Hold Off | Explanation |
|---|---|
| No documented psychosis BEFORE 2021 (before meth use) | Temporal order still favors meth-induced |
| Duration not yet fully established as 6 months independent of drugs | Need longitudinal follow-up |
| DSM-5-TR explicitly excludes schizophrenia if symptoms are due to substance | Substance must be ruled out first |
| 16-38% of meth psychosis cases later get diagnosed as schizophrenia (Maudsley 15th ed.) | Needs monitoring - cannot confirm yet |
| Manic Episode Criterion | Your Patient's Evidence | Match? |
|---|---|---|
| Elevated/irritable mood | Shouted randomly, extreme agitation, explosive rage | ✅ |
| Decreased need for sleep | Stayed awake ALL night cleaning - not complaining of being tired | ✅ |
| Pressured/fast speech | Shouting, rapid incoherent speech | ✅ |
| Increased goal-directed activity | Cleaning the entire house obsessively at 3am in anticipation of visitors | ✅ |
| Psychomotor agitation | Cannot sit still, throwing things, running inside, waving scissors | ✅ |
| Grandiosity-like behavior | "Manago ta kay daghan manulong" ("Let's all bathe because many visitors are coming") - organized behavior around a false sense of occasion | ✅ borderline |
| Risky behavior | Spitting at police, illegal firearm, entering someone's house uninvited | ✅ |
| Psychotic features during mania | Visual hallucinations + delusions during the agitated period | ✅ |
| Functional impairment severe enough for hospitalization | Brought to emergency psychiatric unit | ✅ |
IN JAIL → Crying, incoherent, withdrawn = DEPRESSIVE PHASE?
↓
POST-JAIL → Poor sleep, anhedonia, hygiene neglect = DEPRESSIVE PHASE?
↓
3-2 DAYS PTC → Insomnia, crying, shouting = MIXED/AGITATED?
↓
NIGHT PTC → No sleep, cleaning all night, high energy = MANIC PHASE?
↓
DAY OF CONSULT → Hallucinations, violence, grandiose thinking = MANIA WITH PSYCHOSIS?
| Reason to Hold Off | Explanation |
|---|---|
| Meth itself causes manic-like states | Stimulant intoxication mimics mania almost perfectly |
| Meth withdrawal causes depressive states | The "depressive phase" may just be the crash |
| DSM-5-TR says: if mood episode is fully explained by substance → diagnose substance-induced disorder first | "Stimulant-induced bipolar disorder" is a separate diagnosis |
| No documented manic episode before meth use | Cannot confirm bipolar without pre-drug history |
| Feature | Schizophrenia | Bipolar 1 | Meth-Induced (Actual Dx) |
|---|---|---|---|
| Hallucinations | ✅ Core symptom | ✅ During mania | ✅ Present |
| Delusions | ✅ Core symptom | ✅ During mania | ✅ Present |
| Disorganized speech | ✅ Core symptom | ✅ During mania | ✅ Present |
| Mood episodes | ❌ Not required | ✅ Required (defines it) | ✅ Mimicked by meth |
| Sleep reduction | Possible | ✅ Classic manic feature | ✅ Classic meth feature |
| Duration | 6 months | 1 week mania | Resolves with abstinence |
| Substance as cause | ❌ Must be excluded | ❌ Must be excluded | ✅ IS the cause |
| Pre-drug history | Needed | Needed | No pre-drug psychiatric Hx |
"We considered schizophrenia because the patient meets the symptom criteria - delusions, hallucinations, disorganized speech, disorganized behavior, and functional decline - including psychosis persisting in jail without drug access. We considered Bipolar 1 because his clinical course shows a depressive phase post-jail followed by a manic-like phase with no sleep, high energy, goal-directed activity, agitation, and psychosis. Both are held as differentials pending longitudinal observation after abstinence, as DSM-5-TR requires exclusion of substance causation before diagnosing primary psychiatric disorders."
There's are the medication given tell me it's mode of action class and why it's given
Create a study guide document on meth-induced psychosis treatment
Risperidone 2mg/tab 1 tab now then BID Biperiden 2mg/tab 1 tab ODAM Ascorbic acid 500mg/tab 1 tab TID x 7 days, These are the meds
ls /home/daytona/workspace/ 2>/dev/null || echo "workspace empty or not found"
mkdir -p /home/daytona/workspace/meth-psychosis-guide && cat > /home/daytona/workspace/meth-psychosis-guide/create_doc.js << 'EOF' const { Document, Packer, Paragraph, TextRun, Table, TableRow, TableCell, HeadingLevel, AlignmentType, BorderStyle, WidthType, ShadingType, VerticalAlign, PageNumber, Header, Footer, TableOfContents } = require('docx'); const fs = require('fs'); // Color palette const DARK_BLUE = "1F3864"; const MED_BLUE = "2E75B6"; const LIGHT_BLUE = "D6E4F0"; const ACCENT_RED = "C0392B"; const ACCENT_GREEN = "1E8449"; const ACCENT_ORANGE = "E67E22"; const LIGHT_GRAY = "F2F2F2"; const WHITE = "FFFFFF"; const DARK_TEXT = "1A1A1A"; function heading1(text) { return new Paragraph({ text, heading: HeadingLevel.HEADING_1, spacing: { before: 400, after: 200 }, children: [new TextRun({ text, bold: true, size: 32, color: WHITE, font: "Calibri" })], shading: { type: ShadingType.SOLID, color: DARK_BLUE, fill: DARK_BLUE }, indent: { left: 200, right: 200 }, }); } function heading2(text, color = MED_BLUE) { return new Paragraph({ spacing: { before: 320, after: 120 }, children: [new TextRun({ text, bold: true, size: 26, color: color, font: "Calibri" })], border: { bottom: { style: BorderStyle.SINGLE, size: 6, color: color } }, }); } function heading3(text) { return new Paragraph({ spacing: { before: 200, after: 80 }, children: [new TextRun({ text, bold: true, size: 22, color: DARK_BLUE, font: "Calibri" })], }); } function body(text) { return new Paragraph({ spacing: { before: 60, after: 60 }, children: [new TextRun({ text, size: 20, font: "Calibri", color: DARK_TEXT })], }); } function bullet(text, bold_prefix = "") { return new Paragraph({ spacing: { before: 40, after: 40 }, indent: { left: 400 }, children: [ new TextRun({ text: "• ", size: 20, font: "Calibri", color: MED_BLUE, bold: true }), ...(bold_prefix ? [new TextRun({ text: bold_prefix, size: 20, font: "Calibri", bold: true, color: DARK_TEXT })] : []), new TextRun({ text, size: 20, font: "Calibri", color: DARK_TEXT }), ], }); } function subbullet(text) { return new Paragraph({ spacing: { before: 30, after: 30 }, indent: { left: 720 }, children: [ new TextRun({ text: "◦ ", size: 19, font: "Calibri", color: ACCENT_ORANGE }), new TextRun({ text, size: 19, font: "Calibri", color: DARK_TEXT }), ], }); } function spacer() { return new Paragraph({ spacing: { before: 80, after: 80 }, children: [] }); } function alertBox(label, text, color = ACCENT_RED) { return new Table({ width: { size: 100, type: WidthType.PERCENTAGE }, rows: [ new TableRow({ children: [ new TableCell({ shading: { type: ShadingType.SOLID, color: color, fill: color }, children: [new Paragraph({ children: [ new TextRun({ text: `⚠ ${label}: `, bold: true, size: 20, color: WHITE, font: "Calibri" }), new TextRun({ text, size: 20, color: WHITE, font: "Calibri" }), ], spacing: { before: 80, after: 80 }, indent: { left: 120, right: 120 }, })], }), ], }), ], }); } function infoBox(label, text, bgColor = LIGHT_BLUE) { return new Table({ width: { size: 100, type: WidthType.PERCENTAGE }, rows: [ new TableRow({ children: [ new TableCell({ shading: { type: ShadingType.SOLID, color: bgColor, fill: bgColor }, children: [new Paragraph({ children: [ new TextRun({ text: `${label} `, bold: true, size: 20, color: DARK_BLUE, font: "Calibri" }), new TextRun({ text, size: 20, color: DARK_TEXT, font: "Calibri" }), ], spacing: { before: 80, after: 80 }, indent: { left: 120, right: 120 }, })], }), ], }), ], }); } function makeTable(headers, rows, headerBg = MED_BLUE) { const headerRow = new TableRow({ tableHeader: true, children: headers.map(h => new TableCell({ shading: { type: ShadingType.SOLID, color: headerBg, fill: headerBg }, verticalAlign: VerticalAlign.CENTER, children: [new Paragraph({ children: [new TextRun({ text: h, bold: true, size: 19, color: WHITE, font: "Calibri" })], alignment: AlignmentType.CENTER, spacing: { before: 60, after: 60 }, })], }) ), }); const dataRows = rows.map((row, i) => new TableRow({ children: row.map(cell => new TableCell({ shading: { type: ShadingType.SOLID, color: i % 2 === 0 ? WHITE : LIGHT_GRAY, fill: i % 2 === 0 ? WHITE : LIGHT_GRAY }, children: [new Paragraph({ children: [new TextRun({ text: cell, size: 19, font: "Calibri", color: DARK_TEXT })], spacing: { before: 50, after: 50 }, indent: { left: 80, right: 80 }, })], }) ), }) ); return new Table({ width: { size: 100, type: WidthType.PERCENTAGE }, rows: [headerRow, ...dataRows], }); } // ─── TITLE PAGE ───────────────────────────────────────────────────────────── const titleSection = [ new Paragraph({ spacing: { before: 600, after: 200 }, alignment: AlignmentType.CENTER, children: [new TextRun({ text: "METHAMPHETAMINE-INDUCED", bold: true, size: 56, color: DARK_BLUE, font: "Calibri" })], }), new Paragraph({ spacing: { before: 0, after: 200 }, alignment: AlignmentType.CENTER, children: [new TextRun({ text: "PSYCHOTIC DISORDER", bold: true, size: 56, color: ACCENT_RED, font: "Calibri" })], }), new Paragraph({ spacing: { before: 0, after: 80 }, alignment: AlignmentType.CENTER, children: [new TextRun({ text: "TREATMENT STUDY GUIDE", bold: true, size: 36, color: MED_BLUE, font: "Calibri" })], }), new Paragraph({ spacing: { before: 40, after: 600 }, alignment: AlignmentType.CENTER, children: [new TextRun({ text: "Pharmacology • Mechanisms • Clinical Application", size: 22, color: "666666", font: "Calibri", italics: true })], }), new Paragraph({ spacing: { before: 0, after: 100 }, alignment: AlignmentType.CENTER, border: { top: { style: BorderStyle.SINGLE, size: 6, color: MED_BLUE } }, children: [new TextRun({ text: "Case-Based | DSM-5-TR Aligned | July 2026", size: 18, color: "888888", font: "Calibri" })], }), new Paragraph({ children: [new TextRun({ text: "", break: 1 })] }), ]; // ─── SECTION 1: OVERVIEW ──────────────────────────────────────────────────── const section1 = [ heading1("1. DISEASE OVERVIEW"), spacer(), heading2("What Is Methamphetamine-Induced Psychotic Disorder?"), body("Methamphetamine-induced psychotic disorder is classified under Stimulant-Related Disorders in DSM-5-TR. It is characterized by prominent hallucinations and/or delusions that develop during or after methamphetamine intoxication or withdrawal, and are not better explained by a primary psychotic disorder."), spacer(), makeTable( ["Feature", "Details"], [ ["DSM-5-TR Class", "Stimulant-Related Disorders"], ["Core Symptoms", "Delusions, hallucinations, disorganized speech/behavior"], ["Onset", "During or soon after methamphetamine intoxication or withdrawal"], ["Duration", "Usually resolves in days–weeks; 25% persist at 1 month"], ["Risk of Primary Psychosis", "16–38% later diagnosed with schizophrenia"], ["Violence Risk", "HIGH — psychosis + meth = significantly increased risk"], ] ), spacer(), heading2("Mechanism of Psychosis (Why It Happens)"), bullet("Meth reverses the dopamine transporter (DAT) — actively pumps dopamine OUT of neurons"), bullet("Releases dopamine from vesicles via VMAT2 disruption"), bullet("Blocks dopamine reuptake AND inhibits MAO (monoamine oxidase)"), bullet("Result: massive dopamine flood in mesolimbic pathway → aberrant salience → psychosis"), bullet("With chronic use → dopamine sensitization → psychosis threshold lowers over time"), spacer(), alertBox("KEY DANGER", "Meth users have a FOURFOLD increased risk of extrapyramidal side effects (EPS) with antipsychotics. Drug choice matters critically.", ACCENT_RED), spacer(), ]; // ─── SECTION 2: MEDICATIONS ───────────────────────────────────────────────── const section2 = [ heading1("2. PRESCRIBED MEDICATIONS"), spacer(), // RISPERIDONE new Paragraph({ spacing: { before: 200, after: 100 }, shading: { type: ShadingType.SOLID, color: "1A5276", fill: "1A5276" }, indent: { left: 120, right: 120 }, children: [new TextRun({ text: "DRUG 1: RISPERIDONE 2 mg/tab — 1 tab NOW, then BID", bold: true, size: 26, color: WHITE, font: "Calibri" })], }), spacer(), heading3("Drug Class"), bullet("Second-Generation Antipsychotic (SGA)"), bullet("Also called: Dopamine-Serotonin Antagonist (DSA) under neuroscience-based nomenclature (NbN)"), spacer(), heading3("Mechanism of Action"), bullet("Blocks D2 receptors (dopamine)", "Primary: "), subbullet("Reduces excess dopaminergic activity in the mesolimbic pathway → reduces hallucinations and delusions"), subbullet("D2 blockade in mesocortical pathway → improves thought organization"), bullet("Blocks 5-HT2A receptors (serotonin)", "Secondary: "), subbullet("Serotonin normally inhibits dopamine — blocking 5-HT2A releases this brake → INCREASES dopamine in prefrontal cortex"), subbullet("This dual action improves both POSITIVE symptoms (hallucinations, delusions) and NEGATIVE symptoms (withdrawal, flat affect)"), bullet("Also blocks α1-adrenergic, α2-adrenergic, and H1 receptors (explains sedation and orthostatic hypotension side effects)"), spacer(), heading3("Why Given to This Patient"), bullet("To control active psychosis: hallucinations (sees man and woman), persecutory delusions, disorganized speech"), bullet("Lower EPS propensity than first-generation antipsychotics (haloperidol) — IMPORTANT given meth users' 4x EPS risk"), bullet("Evidence-based choice for meth-induced psychosis with demonstrated efficacy"), bullet("1 tab NOW (loading dose) to achieve faster D2 occupancy threshold for clinical response"), bullet("BID (twice daily) maintains steady-state plasma levels"), spacer(), heading3("Side Effects to Monitor"), makeTable( ["Side Effect", "Why It Happens", "What to Watch For"], [ ["EPS / Dystonia", "D2 blockade in nigrostriatal pathway", "Muscle stiffness, neck spasm, tongue twisting"], ["Akathisia", "D2 blockade", "Restlessness, can't sit still, feels urge to move"], ["Sedation", "H1 and α1 blockade", "Excessive sleepiness"], ["Orthostatic hypotension", "α1 blockade", "Dizziness when standing up"], ["Hyperprolactinemia", "D2 blockade in tuberoinfundibular pathway", "Galactorrhea, menstrual changes"], ["QTc prolongation", "Cardiac channel effects", "Check ECG before starting"], ["Weight gain / metabolic", "Histamine and serotonin effects", "Monitor glucose, lipids"], ] ), spacer(), infoBox("📌 NOTE:", "Haloperidol is CONTRAINDICATED in meth users — the risk of acute dystonia is too high. Risperidone is the safer atypical choice.", LIGHT_BLUE), spacer(), // BIPERIDEN new Paragraph({ spacing: { before: 200, after: 100 }, shading: { type: ShadingType.SOLID, color: "145A32", fill: "145A32" }, indent: { left: 120, right: 120 }, children: [new TextRun({ text: "DRUG 2: BIPERIDEN 2 mg/tab — 1 tab ODAM (Once Daily AM)", bold: true, size: 26, color: WHITE, font: "Calibri" })], }), spacer(), heading3("Drug Class"), bullet("Anticholinergic (Antimuscarinic) Agent"), bullet("Antiparkinson drug — used specifically to prevent/treat EPS from antipsychotics"), spacer(), heading3("Mechanism of Action"), body("To understand biperiden, you need to understand the dopamine-acetylcholine BALANCE in the brain's motor system (basal ganglia):"), spacer(), makeTable( ["Normal State", "When Antipsychotic (Risperidone) Blocks D2"], [ ["Dopamine and acetylcholine are BALANCED in the striatum", "Dopamine activity drops → acetylcholine becomes DOMINANT"], ["Smooth voluntary movement", "Excess ACh → tremor, rigidity, muscle stiffness = EPS"], ], ACCENT_GREEN ), spacer(), bullet("Biperiden blocks muscarinic (M1) receptors in the striatum"), bullet("This REDUCES excess acetylcholine activity that dominates when dopamine is blocked by risperidone"), bullet("Restores dopamine-acetylcholine balance → prevents EPS"), spacer(), heading3("Why Given to This Patient"), bullet("Prophylactic co-prescription with risperidone to prevent EPS (especially important here — meth users have 4x EPS risk)"), bullet("Given ODAM (once daily, morning) to maintain daytime coverage when patient is most active and EPS most visible"), bullet("Prevents: drug-induced parkinsonism (tremor, rigidity, bradykinesia), acute dystonia (neck/jaw muscle spasms), akathisia"), spacer(), heading3("Side Effects to Monitor"), makeTable( ["Side Effect", "Why It Happens"], [ ["Dry mouth", "Reduced salivary gland secretion (muscarinic blockade)"], ["Blurred vision", "Cycloplegia (ciliary muscle relaxation)"], ["Constipation", "Reduced GI motility"], ["Urinary retention", "Relaxation of detrusor muscle"], ["Tachycardia", "Blockade of cardiac M2 receptors"], ["Confusion / memory impairment", "Central anticholinergic effects — especially in elderly"], ["Worsens tardive dyskinesia", "Long-term use can unmask or worsen TD"], ] ), spacer(), alertBox("WARNING", "Anticholinergics like biperiden can be ABUSED for their mild euphoric/dissociative effects — monitor for misuse, especially in a patient with known substance use disorder.", ACCENT_ORANGE), spacer(), // ASCORBIC ACID new Paragraph({ spacing: { before: 200, after: 100 }, shading: { type: ShadingType.SOLID, color: "7D6608", fill: "7D6608" }, indent: { left: 120, right: 120 }, children: [new TextRun({ text: "DRUG 3: ASCORBIC ACID (Vitamin C) 500 mg/tab — 1 tab TID x 7 days", bold: true, size: 26, color: WHITE, font: "Calibri" })], }), spacer(), heading3("Drug Class"), bullet("Water-soluble vitamin"), bullet("Antioxidant / nutritional supplement"), spacer(), heading3("Mechanism of Action"), bullet("Potent antioxidant — donates electrons to neutralize reactive oxygen species (ROS) and free radicals"), bullet("Methamphetamine causes massive oxidative stress in the brain:", "Meth-specific: "), subbullet("Dopamine auto-oxidation during massive dopamine release generates toxic quinones and hydrogen peroxide"), subbullet("These free radicals damage dopamine nerve terminals → causes the long-term neurotoxicity of meth"), bullet("Ascorbic acid scavenges these free radicals → protects neurons from oxidative damage"), bullet("Also supports collagen synthesis, immune function, and wound healing (important in a malnourished, neglected-hygiene patient)"), bullet("May reduce risperidone-related oxidative side effects and support general metabolic recovery"), spacer(), heading3("Why Given to This Patient"), bullet("Neuroprotection: counteracts meth-induced oxidative damage to dopaminergic neurons"), bullet("Nutritional replenishment: patient had poor appetite and hygiene neglect — likely nutritionally depleted"), bullet("Short course (7 days) = acute supplementation during the most vulnerable recovery phase"), bullet("TID dosing ensures sustained antioxidant levels throughout the day (Vitamin C has short half-life — excreted rapidly in urine)"), bullet("Low risk, high benefit — safe adjunct to psychiatric treatment"), spacer(), infoBox("💡 CLINICAL PEARL:", "Meth causes selective destruction of dopamine and serotonin nerve terminals through oxidative stress. Antioxidants like Vitamin C may help blunt this neurotoxicity during the acute phase.", LIGHT_BLUE), spacer(), ]; // ─── SECTION 3: DRUG COMPARISON TABLE ─────────────────────────────────────── const section3 = [ heading1("3. MEDICATION SUMMARY AT A GLANCE"), spacer(), makeTable( ["Drug", "Class", "MOA (Simple)", "Why Given", "Key Side Effect"], [ ["Risperidone 2mg BID", "SGA / Dopamine-Serotonin Antagonist", "Blocks D2 + 5-HT2A receptors", "Treat hallucinations, delusions, agitation", "EPS, sedation, QTc prolongation"], ["Biperiden 2mg ODAM", "Anticholinergic (Antiparkinson)", "Blocks M1 muscarinic receptors → restores DA-ACh balance", "Prevent EPS from risperidone", "Dry mouth, blurred vision, urinary retention"], ["Ascorbic Acid 500mg TID x7d", "Antioxidant / Vitamin Supplement", "Scavenges free radicals from meth-induced oxidative stress", "Neuroprotection + nutritional support", "Very safe; GI upset at high doses"], ] ), spacer(), ]; // ─── SECTION 4: THE DRUG LOGIC CHAIN ──────────────────────────────────────── const section4 = [ heading1("4. WHY THESE 3 DRUGS TOGETHER — THE CLINICAL LOGIC"), spacer(), new Table({ width: { size: 100, type: WidthType.PERCENTAGE }, rows: [ new TableRow({ children: [ new TableCell({ shading: { type: ShadingType.SOLID, color: "1A5276", fill: "1A5276" }, children: [new Paragraph({ alignment: AlignmentType.CENTER, spacing: { before: 100, after: 100 }, children: [new TextRun({ text: "RISPERIDONE", bold: true, size: 22, color: WHITE, font: "Calibri" })] })], }), new TableCell({ shading: { type: ShadingType.SOLID, color: MED_BLUE, fill: MED_BLUE }, children: [new Paragraph({ alignment: AlignmentType.CENTER, spacing: { before: 100, after: 100 }, children: [new TextRun({ text: "→", bold: true, size: 22, color: WHITE, font: "Calibri" })] })], }), new TableCell({ shading: { type: ShadingType.SOLID, color: "145A32", fill: "145A32" }, children: [new Paragraph({ alignment: AlignmentType.CENTER, spacing: { before: 100, after: 100 }, children: [new TextRun({ text: "BIPERIDEN", bold: true, size: 22, color: WHITE, font: "Calibri" })] })], }), new TableCell({ shading: { type: ShadingType.SOLID, color: MED_BLUE, fill: MED_BLUE }, children: [new Paragraph({ alignment: AlignmentType.CENTER, spacing: { before: 100, after: 100 }, children: [new TextRun({ text: "+", bold: true, size: 22, color: WHITE, font: "Calibri" })] })], }), new TableCell({ shading: { type: ShadingType.SOLID, color: "7D6608", fill: "7D6608" }, children: [new Paragraph({ alignment: AlignmentType.CENTER, spacing: { before: 100, after: 100 }, children: [new TextRun({ text: "ASCORBIC ACID", bold: true, size: 22, color: WHITE, font: "Calibri" })] })], }), ]}), new TableRow({ children: [ new TableCell({ shading: { type: ShadingType.SOLID, color: LIGHT_GRAY, fill: LIGHT_GRAY }, children: [new Paragraph({ alignment: AlignmentType.CENTER, spacing: { before: 80, after: 80 }, children: [new TextRun({ text: "Control the psychosis", size: 18, color: DARK_TEXT, font: "Calibri", italics: true })] })], }), new TableCell({ shading: { type: ShadingType.SOLID, color: WHITE, fill: WHITE }, children: [new Paragraph({ children: [] })] }), new TableCell({ shading: { type: ShadingType.SOLID, color: LIGHT_GRAY, fill: LIGHT_GRAY }, children: [new Paragraph({ alignment: AlignmentType.CENTER, spacing: { before: 80, after: 80 }, children: [new TextRun({ text: "Prevent drug side effects", size: 18, color: DARK_TEXT, font: "Calibri", italics: true })] })], }), new TableCell({ shading: { type: ShadingType.SOLID, color: WHITE, fill: WHITE }, children: [new Paragraph({ children: [] })] }), new TableCell({ shading: { type: ShadingType.SOLID, color: LIGHT_GRAY, fill: LIGHT_GRAY }, children: [new Paragraph({ alignment: AlignmentType.CENTER, spacing: { before: 80, after: 80 }, children: [new TextRun({ text: "Protect the brain + replenish", size: 18, color: DARK_TEXT, font: "Calibri", italics: true })] })], }), ]}), ], }), spacer(), body("Each drug has a distinct and non-overlapping role. This is rational polypharmacy — every medication addresses a specific clinical need:"), spacer(), bullet("Risperidone controls the ACTIVE PSYCHOSIS (hallucinations, delusions, agitation)"), bullet("Biperiden PROTECTS AGAINST the most common and dangerous side effect of risperidone in this patient (EPS)"), bullet("Ascorbic Acid SUPPORTS RECOVERY by fighting oxidative damage from years of meth use and correcting nutritional deficiency"), spacer(), ]; // ─── SECTION 5: GENERAL TREATMENT PRINCIPLES ──────────────────────────────── const section5 = [ heading1("5. GENERAL TREATMENT PRINCIPLES"), spacer(), heading2("Acute Phase Management (ED / Admission)", ACCENT_RED), bullet("First priority: SAFETY — de-escalate, remove weapons, protect patient and staff"), bullet("Benzodiazepines (diazepam 5–10mg q4–6h) — first-line for agitation before antipsychotics are effective"), bullet("Do NOT give olanzapine + benzodiazepines together — risk of respiratory depression/death"), bullet("Aripiprazole preferred for rapid tranquilization alongside benzodiazepines"), bullet("AVOID haloperidol — 4x EPS risk in meth users → acute dystonia"), bullet("Medical workup: urine drug screen, blood glucose, CBC, BMP, ECG, vital signs"), spacer(), heading2("Subacute Phase (Inpatient Ward)"), bullet("Continue antipsychotic at therapeutic dose — most symptoms resolve in 2–3 weeks"), bullet("Monitor for EPS daily — biperiden coverage essential"), bullet("Sleep hygiene — meth severely disrupts sleep; normalize sleep-wake cycle"), bullet("Nutritional support — patient had poor appetite; monitor weight, hydration"), bullet("Family psychoeducation — explain the illness, prognosis, triggers"), spacer(), heading2("Discharge Planning"), bullet("Review antipsychotic need at 2–3 weeks — do NOT continue prophylactically if psychosis resolves"), bullet("If psychosis persists >1 month → reassess for primary psychotic disorder (schizophrenia)"), bullet("Refer to substance use disorder treatment program"), bullet("Address psychosocial stressors: family reunification, custody of child, housing"), spacer(), heading2("What NOT to Use"), makeTable( ["Drug", "Why Avoid"], [ ["Haloperidol", "4x increased EPS/dystonia risk in meth users (Maudsley Guidelines)"], ["Olanzapine + Benzodiazepine together", "Risk of fatal respiratory depression"], ["SSRIs (in active meth use)", "Dangerous drug interaction + increased disengagement"], ["TCAs (in active substance use)", "Cardiotoxicity risk"], ["Prophylactic long-term antipsychotics", "No evidence for benefit in meth-induced psychosis"], ], ACCENT_RED ), spacer(), ]; // ─── SECTION 6: QUICK RECALL CARDS ────────────────────────────────────────── const section6 = [ heading1("6. QUICK RECALL — EXAM READY"), spacer(), heading2("One-Liner for Each Drug"), makeTable( ["Drug", "One Liner"], [ ["Risperidone", "Atypical antipsychotic; blocks D2 + 5-HT2A; controls psychosis with lower EPS risk than typical agents"], ["Biperiden", "Anticholinergic; blocks M1 receptors; prevents EPS by restoring dopamine-acetylcholine balance"], ["Ascorbic Acid", "Antioxidant vitamin; neutralizes meth-induced oxidative free radicals; neuroprotective + nutritional"], ] ), spacer(), heading2("Key Numbers to Remember"), bullet("25% of patients still have symptoms 1 month after meth use"), bullet("16–38% of meth psychosis cases are later diagnosed as schizophrenia"), bullet("4x increased EPS risk in meth users — always consider anticholinergic cover"), bullet("D2 occupancy threshold for antipsychotic effect: >50%"), bullet("Stimulant use disorder: 2–3 criteria = mild; 4–5 = moderate; ≥6 = SEVERE"), bullet("Manic episode duration for Bipolar 1: ≥1 week (or any duration if hospitalized)"), bullet("Schizophrenia duration criterion: 6 months total (≥1 month active symptoms)"), spacer(), heading2("The Psychosis Triad in This Patient"), makeTable( ["Symptom Type", "What It Is", "Evidence in Patient"], [ ["Hallucination", "Perception with NO real stimulus", "'Naa koy makit-an babaye ug lalaki' (sees man & woman)"], ["Delusion", "Fixed false belief, unshakeable", "Insisted partner still home; believed children arriving all night"], ["Disorganized Speech", "Incoherent, loose associations", "'Pataka na ug sturya' — spoke incoherently in jail and at home"], ] ), spacer(), ]; // ─── ASSEMBLE DOCUMENT ─────────────────────────────────────────────────────── const doc = new Document({ styles: { default: { document: { run: { font: "Calibri", size: 20, color: DARK_TEXT }, }, }, }, sections: [ { headers: { default: new Header({ children: [ new Paragraph({ border: { bottom: { style: BorderStyle.SINGLE, size: 4, color: MED_BLUE } }, children: [ new TextRun({ text: "METH-INDUCED PSYCHOTIC DISORDER — TREATMENT STUDY GUIDE", size: 16, color: MED_BLUE, font: "Calibri", bold: true }), new TextRun({ text: " | VSMMC-CBS CMU Case | July 2026", size: 16, color: "888888", font: "Calibri" }), ], }), ], }), }, footers: { default: new Footer({ children: [ new Paragraph({ border: { top: { style: BorderStyle.SINGLE, size: 4, color: MED_BLUE } }, alignment: AlignmentType.CENTER, children: [ new TextRun({ text: "Sources: Maudsley Prescribing Guidelines 15th ed. | Kaplan & Sadock's Comprehensive Textbook of Psychiatry | Goodman & Gilman's Pharmacology | Harrison's Internal Medicine 22E Page ", size: 16, color: "888888", font: "Calibri" }), new TextRun({ children: [new PageNumber()], size: 16, color: MED_BLUE, font: "Calibri" }), ], }), ], }), }, children: [ ...titleSection, ...section1, ...section2, ...section3, ...section4, ...section5, ...section6, ], }, ], }); Packer.toBuffer(doc).then(buffer => { fs.writeFileSync("/home/daytona/workspace/meth-psychosis-guide/MethPsychosis_StudyGuide.docx", buffer); console.log("SUCCESS: Document created"); }).catch(err => { console.error("ERROR:", err.message); }); EOF echo "Script written"
cd /home/daytona/workspace/meth-psychosis-guide && node create_doc.js
~/meth-psychosis-guide/create_doc.js
Successfully replaced 1 instance(s) of the string in '/home/daytona/workspace/meth-psychosis-guide/create_doc.js'
cd /home/daytona/workspace/meth-psychosis-guide && node create_doc.js
python /home/daytona/skills/docx/scripts/office/validate.py /home/daytona/workspace/meth-psychosis-guide/MethPsychosis_StudyGuide.docx
ls -lh /home/daytona/workspace/meth-psychosis-guide/MethPsychosis_StudyGuide.docx && python3 -c "import zipfile; z=zipfile.ZipFile('/home/daytona/workspace/meth-psychosis-guide/MethPsychosis_StudyGuide.docx'); print('Valid ZIP, files:', z.namelist()[:5])"
MethPsychosis StudyGuide
Word Document · DOCX
| Drug | Covered |
|---|---|
| Risperidone 2mg BID | Class (SGA/DSA), D2 + 5-HT2A MOA, why chosen, side effect table |
| Biperiden 2mg ODAM | Class (anticholinergic), M1 receptor MOA, dopamine-ACh balance explained, warnings |
| Ascorbic Acid 500mg TID x7d | Antioxidant MOA, meth oxidative stress mechanism, why 7-day course, TID rationale |
Teach me how it helps ...
PROBLEM 1 PROBLEM 2 PROBLEM 3
His brain is → The medicine we His neurons are
on fire with give to fix #1 being destroyed
psychosis will create by years of
new problems meth oxidative
(EPS) damage
NORMAL SYNAPSE:
Meth neuron → releases dopamine → hits D2 receptor → "THREAT! THREAT! THREAT!"
AFTER RISPERIDONE:
Meth neuron → releases dopamine → tries to hit D2 receptor
↓
RISPERIDONE IS SITTING THERE
blocking the receptor like a
bouncer at a door
↓
Signal is BLOCKED
↓
Brain calms down
| His Symptom | Risperidone Effect | Timeline |
|---|---|---|
| Seeing man and woman | Hallucinations reduce | 3–7 days |
| Believing partner is home | Delusions soften | 1–2 weeks |
| Incoherent speech | Thought organization improves | Days-weeks |
| Punching / throwing things | Agitation reduces | 1–3 days |
| Overall psychosis | Resolves | 2–3 weeks usually |
NORMAL NIGROSTRIATAL PATHWAY:
Dopamine ←→ Acetylcholine
(They balance each other for smooth movement)
AFTER RISPERIDONE BLOCKS D2:
Dopamine activity ↓↓↓
Acetylcholine goes UNOPPOSED
↓
Excess acetylcholine = muscle stiffness, tremor, spasm
↓
EXTRAPYRAMIDAL SIDE EFFECTS (EPS)
Methamphetamine users have a FOURFOLD increased risk of developing EPS
AFTER RISPERIDONE:
Dopamine (blocked) ← ← ← ← ← ← IMBALANCE → → → → → Acetylcholine (dominant)
causing EPS
BIPERIDEN STEPS IN:
Biperiden blocks M1 muscarinic receptors (acetylcholine receptors)
↓
Reduces the excess acetylcholine activity
↓
Balance is RESTORED:
Dopamine (low but stable) ←→ Acetylcholine (now also reduced)
↓
No EPS. Smooth movement. No muscle spasms.
WITHOUT BIPERIDEN:
DA ↓↓ ACh ↑↑
───────────────────────────
↙ TILTED = EPS
WITH BIPERIDEN:
DA ↓↓ ACh ↓ (biperiden blocks it)
──────────────────────────
─── BALANCED = No EPS
Meth → massive dopamine release
↓
Excess dopamine → auto-oxidizes (reacts with oxygen)
↓
Creates FREE RADICALS (reactive oxygen species)
↓
Free radicals attack the dopamine nerve terminals
↓
Nerve terminals are DAMAGED or DESTROYED
↓
Permanent loss of dopamine neurons
↓
Long-term cognitive damage, depression, memory loss
Free radical (dangerous): O• ←── ASCORBIC ACID donates an electron
↓
Free radical becomes NEUTRALIZED
↓
No more damage to the nerve terminal
YOUR PATIENT'S BRAIN
│
┌──────────────────────┼──────────────────────┐
│ │ │
PSYCHOSIS EPS RISK OXIDATIVE
(dopamine (from meth DAMAGE
flood) + risperidone) (from 4 years
│ │ of meth)
│ │ │
▼ ▼ ▼
RISPERIDONE BIPERIDEN ASCORBIC ACID
blocks D2 + blocks M1 neutralizes
5-HT2A → muscarinic → free radicals →
stops the restores protects
psychosis DA-ACh balance neurons
│ │ │
└──────────────────────┼──────────────────────┘
│
PATIENT RECOVERS:
• Psychosis resolves
• No EPS develops
• Brain protected
from further damage
| Drug | What it does in one line |
|---|---|
| Risperidone | "Blocks the dopamine signal that is creating the false reality" |
| Biperiden | "Fixes the muscle stiffness that risperidone would otherwise cause" |
| Ascorbic Acid | "Mops up the chemical damage meth left behind in his brain cells" |
"Because meth users have a fourfold increased EPS risk, giving risperidone without biperiden would very likely cause acute dystonia. And because years of meth use caused oxidative neuronal damage, ascorbic acid addresses an entirely different problem that risperidone cannot - neuroprotection. Each drug has a distinct, non-overlapping target."